Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cerus Corp (CERS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Detailed Research: Economic Perspectives on REV Group, CoreLogic, Nu Skin Enterprises, Torchmark, Evertec, and Cerus -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of REV Group, Inc. (NYSE:REVG),...

EVTC : 16.05 (-0.93%)
REVG : 26.95 (-0.19%)
TMK : 86.17 (-0.24%)
CLGX : 45.22 (-0.07%)
CERS : 4.18 (+0.48%)
NUS : 71.66 (+0.42%)
Cerus Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriter's Option to Purchase Additional Shares

Cerus Corporation (NASDAQ:CERS) today announced the closing of a registered underwritten public offering of its common stock, which included the sale of additional shares of common stock...

CERS : 4.18 (+0.48%)
Cerus Announces Pricing of Public Offering of Common Stock

Cerus Corporation (NASDAQ:CERS) today announced the pricing of a registered underwritten public offering of its common stock for proceeds of $50.0 million, before deducting estimated offering...

CERS : 4.18 (+0.48%)
Cerus Announces Public Offering of Common Stock

Cerus Corporation (NASDAQ: CERS) today announced that it has commenced a registered underwritten public offering of $50.0 million of its common stock. In addition, Cerus has granted the underwriter...

CERS : 4.18 (+0.48%)
Today's Research Reports on Stocks to Watch: Cerus Corporation and Halozyme Therapeutics

NEW YORK, NY / ACCESSWIRE / January 25, 2018 / Cerus shares skyrocketed to a new high on Wednesday after the company announced positive results from its clinical trial of Intercept. Halozyme Therapeutics...

CERS : 4.18 (+0.48%)
HALO : 19.24 (+4.11%)
Noteworthy Monday Option Activity: CERS, STMP, SIG

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Cerus Corp. , where a total volume of 3,171 contracts has been traded thus far today,...

CERS : 4.18 (+0.48%)
Cerus Corporation Announces Preliminary Product Revenue Results for Fourth Quarter and Full Year 2017

Cerus Corporation (NASDAQ: CERS) today announced unaudited preliminary product revenue for the fourth quarter and full year 2017 and provided 2018 product revenue guidance.

CERS : 4.18 (+0.48%)
Universal Health Grows Inorganically, Rising Costs a Drag

Universal Health's (UHS) top line grows on solid Acute Care and Behavioral Health platforms. Nevertheless, surging level of debt bothers.

UHS : 115.47 (-1.46%)
AMED : 57.79 (+1.62%)
CERS : 4.18 (+0.48%)
ALGN : 252.14 (-1.30%)
Zacks.com highlights: Drive Shack, Cerus, ReWalk Robotics, Aerohive Networks and Cloud Peak Energy

Zacks.com highlights: Drive Shack, Cerus, ReWalk Robotics, Aerohive Networks and Cloud Peak Energy

HIVE : 4.15 (-2.12%)
RWLK : 1.10 (-4.35%)
CLD : 3.24 (+2.21%)
CERS : 4.18 (+0.48%)
DS : 5.17 (-2.64%)
5 Breakout Stocks Offering Admirable Returns

Nearly as favored a strategy as it is divisive, picking breakout stocks is one of the most used techniques for active investors.

HIVE : 4.15 (-2.12%)
RWLK : 1.10 (-4.35%)
CLD : 3.24 (+2.21%)
CERS : 4.18 (+0.48%)
DS : 5.17 (-2.64%)
Cerus Corporation Receives IDE Approval to Initiate Phase III ReCePI Study

Cerus Corporation (NASDAQ: CERS) today announced it has received an investigational device exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to initiate ReCePI (A...

CERS : 4.18 (+0.48%)
Technical Insights on Biotech Stocks -- Cara Therapeutics, Catabasis Pharma, Cerus, and Genocea Biosciences

If you want a Stock Review on CARA, CATB, CERS, or GNCA then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. On Friday, benchmark US indices were in bullish...

CARA : 13.81 (unch)
CATB : 1.54 (-1.28%)
GNCA : 1.00 (unch)
CERS : 4.18 (+0.48%)
Cerus Corporation Reports Third Quarter 2017 Results

Cerus Corporation (NASDAQ:CERS) today announced financial results for the third quarter ended September 30, 2017.

CERS : 4.18 (+0.48%)
Cerus to Present at Two Upcoming Conferences

Cerus Corporation (NASDAQ:CERS) announced today that management will present at two upcoming investor conferences:

CERS : 4.18 (+0.48%)
Cerus and Kedrion Biopharma Enter Distribution Agreement for the Full INTERCEPT Blood System Portfolio in Italy

Cerus Corporation (NASDAQ:CERS) announced today that it has entered into an agreement with Kedrion Biopharma to distribute the full complement of INTERCEPT Blood System products in Italy....

CERS : 4.18 (+0.48%)
Cerus Announces Agreement with Transfusion Center of the Community of Madrid

Cerus Corporation (NASDAQ:CERS) announced today that it has entered into a supply agreement with Centro de Transfusion de la Comunidad de Madrid (CTCM) for the INTERCEPT Blood System for...

CERS : 4.18 (+0.48%)
Cerus Announces National German Reimbursement for Pathogen Inactivated Platelets

Cerus Corporation (NASDAQ:CERS) announced today that the Institute for the Hospital Remuneration System (Institut fur das Entgeltsystem im Krankenhaus, or InEK) in Germany will include pathogen-inactivated...

CERS : 4.18 (+0.48%)
Cerus to Release Third Quarter 2017 Results on November 2, 2017

Cerus Corporation (NASDAQ:CERS) announced today that its third quarter results will be released on Thursday, November 2, 2017, after the close of the stock market. The company will host a...

CERS : 4.18 (+0.48%)
Cerus Corporation (CERS) Looks Good: Stock Adds 8.2% in Session

Cerus Corporation (CERS) saw its shares rise over 8% on the day on the back of the news of a favorable regulatory development.

ESLOY : 67.3250 (+0.14%)
CERS : 4.18 (+0.48%)
Cerus Announces First Biologics License Application Approval for U.S. Blood Center Customer

Cerus Corporation (NASDAQ:CERS) announced today that Rhode Island Blood Center received approval by the U.S. Food and Drug Administration (FDA) on their Biologics License Application (BLA)...

CERS : 4.18 (+0.48%)

Van Meerten Stock Picks

Nvidia - My Favorite S\&P 500 Large Cap Stock
$NVDA Summary96% technical by signals.
NVDA -7.57
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Mar E-mini S&Ps ( ESH18 unch) this morning are down -0.05% and European stocks are down -0.57% after European manufacturing activity slowed more than expected this month. Losses were contained as the 10-year... Read More

Chart of the Day

Match Group Inc CS (MTCH)

Match Group (MTCH) is the Barchart Chart of the Day.  The popular on-line dating company has a Trend Spotter buy signal, a Weighted Alpha of 190.79+ and gained 152.84% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures showed fractional gains on Wednesday. The weekly EIA report will be delayed until Thursday morning, as ethanol production fell to 1.016 million bpd in last week’s report. Ahead of the USDA Ag Outlook Forum, a Reuters survey of anal...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.